Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Wezenla 130mg/26ml concentrate for solution for infusion vials (Amgen Ltd) |
| Virtual Medicinal Product | Ustekinumab 130mg/26ml solution for infusion vials |
| Name | Wezenla 130mg/26ml concentrate for solution for infusion vials |
| Abbreviated name | Wezenla 130mg/26ml concentrate for inf vials |
| Supplier | Amgen Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✓ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intravenous |
| Actual Medicinal Product Packs | |
| Wezenla 130mg/26ml concentrate for solution for infusion vials (Amgen Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_9.0.0_20240902000001, imported on 2nd September 2024 at 04:54:12.